Platelet Rich Plasma

Platelet Rich Plasma Market Reaches $ 715.65 Million Mark by 2030 Platelet Rich Plasma Market (By Product: Leukocyte Rich PRP, Pure PRP, and Leukocyte Rich Fibrin: By Origin: Allogeneic PRP, Autologous PRP, and Homologous PRP; By Application: Cosmetic Surgery & Dermatology, Orthopedic Surgery, General Surgery, Ophthalmic Surgery, Neurosurgery, and Others) - Global Industry Analysis, Size, Share, Growth, Trends Analysis, Regional Outlook and Forecasts, 2021 - 2030

Share This Article

The platelet rich plasma market is expected to exhibit a CAGR of 11.6% from 2021 to 2030 and is projected to reach US$ 715.65 million by 2030, according to a 2021 study by Precedence Research, the Canada based market insight company.

The report contains 150+ pages with detailed analysis. The study provides the overall revenue of the global platelet rich plasma market from 2017 to 2030, considering 2020 as the base year and 2030 as the forecast year.

The global platelet rich plasma market research report gives a brief summary of definitions, size analysis, and place of production, sales, applications, types, and major players/key vendors of the platelet rich plasma industry. The report presents fresh perspectives on opportunities and challenges in a significantly transformed post-COVID-19 marketplace. This research study also integrates Industry Chain analysis and Porter’s Five Forces Analysis. Further, this report offers a competitive scenario that comprises collaborations, market concentration rate and expansions, mergers & acquisitions undertaken by companies.

We customize your report according to your research need. REQUEST CUSTOMIZED COPY OF REPORT (Including TOC, List of Tables & Figures, and Chart) @ https://www.precedenceresearch.com/customization/1237

Growth Factors

Rising elderly population and intensifying orthopedic conditions are probable to lift the growth of global platelet rich plasma market. As per data published by National Center for Biotechnology Information, more than 1.4 million people are recognized with fractures related to osteoporosis every year. Besides, escalating attentiveness associated to platelet rich plasma therapy for dental treatment is likely to boost the market expansion.

Research and Development in drug delivery system for platelet-rich bioactive molecules is anticipated to propose profitable development prospects for companies operational in the global platelet-rich plasma market. For example, in 2020, researchers from Czech Republic, Charles University, and Institute of Experimental Medicine of the Czech Academy of Sciences stated development of an easy delivery system to extend the effects of the bioactive molecules released by platelets.

PRP comprise 7 growth factors, and it can be employed for numerous treatments, including severe ligament, and muscle wounds, chronic tendon wounds, knee arthritis, surgery, pain and fractures. In orthopedics, the usage of PRP is likely to upsurge over the year to come. Due to cumulative elderly populace, incidence of doctor-diagnosed arthritis is predictable to surge suggestively within prediction period. The popularity of PRP is on the escalation, still its true efficiency is yet to be completely recognized. The PRP is extensively utilized in surgery to recover torn knee ligaments, like the anterior circulate ligament. The PRP eases the rapid curing of the tissue afterward surgical actions.

Regional Snapshots

North America gathered major revenue cut in the global platelet-rich plasma market due to occurrence of noteworthy players who are functioning in the field of PRP market. Broadening application ranges of platelet rich plasma in therapeutics and snowballing number of patients diagnosed with orthopedic illnesses are few influences accountable for the leading expansion of the market in this region.

Asia Pacific is anticipated to exhibit rapid growth throughout assessment duration. Cumulative number of cosmetic surgeries to improve facial features in nations such as Thailand, Korea, and India are projected to boost growth of the market in this region. Further, rise in outlay in health care infrastructure, economy development, huge pool of patients with rheumatology and orthopedic ailments in evolving nations such as India, China, Malaysia, and South Korea, and upsurge in per capita health care spending in the region are further flourishing the market prospects.

Report Highlights

  • International market participants like Harvest, Cesca, Biomet and Arthrex are reinforcing their prevailing distribution networks to augment their market footprint and revenue share
  • Among different applications, Orthopedics segment help majority of the market share in terms of revenue in 2019. This is on account of the fact that number of orthopedic problems such as quadriceps, rotator cuff, Achilles tendon injuries, hamstring, and tennis elbow can be treated effectively with PRP

Top Players Contending in the Market:

The key companies are aiming towards advanced innovations and are predictable to dominate the target market. Foremost players inspiring in the global platelet rich plasma market are as follows:

  • Zimmer Biomet
  • Arthrex, Inc.
  • Harvest Technologies Corporation
  • Stryker Corporation
  • DePuy Synthes, Inc.
  • Cesca Therapeutics, Inc.
  • AdiStem Ltd.
  • Exactech Inc.
  • ISTO Biologics
  • Nuo Therapeutics

Market Segmentation

By Product

  • Leukocyte Rich PRP
  • Pure PRP
  • Leukocyte Rich Fibrin

By Origin

  • Allogeneic PRP
  • Autologous PRP
  • Homologous PRP

By Application

  • Cosmetic Surgery & Dermatology
  • Orthopedic Surgery
  • General Surgery
  • Ophthalmic Surgery
  • Neurosurgery
  • Other

Regional Segmentation

  • North America (U.S. and Canada)
  • Europe (Germany, France, U.K., Italy, Spain, Rest of Europe)
  • Asia-Pacific (China, Japan, India, Southeast Asia and Rest of APAC)
  • Latin America (Brazil and Rest of Latin America)
  • Middle East and Africa (GCC, North Africa, South Africa, Rest of MEA)

Some of the key highlights covered in the report include:

Market Demand-Supply Analysis – The report covers detailed insights into demand and supply forces prevailing in the global platelet rich plasma market. It examines trends and factors influencing demand for platelet rich plasma globally and gauges the impact of the same on the production.

Pricing Analysis – The report presents an exclusive pricing analysis. It compares pricing strategies adopted by the leading market players and identifies the most remunerative strategies.

Market Segmentation – The report segments the global market in terms of diverse criteria. It identifies the leading segment within each category and identifies growth drivers and restraints affecting growth across each segment.

Regional Analysis – The report segments the market in terms of North America, Europe, Latin America, Asia Pacific, and Rest of the World in terms of region. It has chapters exclusively dedicated to analyzing growth trends across each region. It identifies growth drivers as well challenges affecting demand for platelet rich plasma across the world.

Competitive Analysis – Some of the leading market players are profiled in the report on platelet rich plasma. The report offers an estimation of share individually help by the market players and determines the impact of some of their popular strategies.

COVID-19 Impact Analysis – This chapter is exclusively dedicated to gauging how the market has evolved or will develop in the post-pandemic era.

Growth Recommendations – In the end, the report presents valuable recommendations to ready businesses for unforeseen challenges in the near future.

Why should you invest in this report?

If you are aiming to enter the global platelet rich plasma market, this report is a comprehensive guide that provides crystal clear insights into this niche market. All the major application areas for platelet rich plasma are covered in this report and information is given on the important regions of the world where this market is likely to boom during the forecast period of 2021-2030 so that you can plan your strategies to enter this market accordingly.

Besides, through this report, you can have a complete grasp of the level of competition you will be facing in this hugely competitive market and if you are an established player in this market already, this report will help you gauge the strategies that your competitors have adopted to stay as market leaders in this market. For new entrants to this market, the voluminous data provided in this report is invaluable.

TABLE OF CONTENT

Chapter 1. Introduction

1.1. Research Objective
1.2. Scope of the Study
1.3. Definition

Chapter 2. Research Methodology

2.1. Research Approach
2.2. Data Sources
2.3. Assumptions& Limitations

Chapter 3. Executive Summary

3.1. Market Snapshot

Chapter 4. Platelet Rich Plasma Market Variables and Scope

4.1. Introduction
4.2. Market Classification and Scope

Chapter 5. COVID 19 Impact on Platelet Rich Plasma Market

5.1. Covid-19: Platelet Rich Plasma Industry Impact
5.2. Platelet Rich Plasma Business Impact Assessment: Covid-19
5.2.1. Services Challenges/Disruption
5.2.2. Market Trends and Platelet Rich Plasma Opportunities in the COVID-19 Landscape for Major Markets
5.3. Strategic Measures against Covid-19
5.3.1. Government Support and Initiative to Combat Covid-19
5.3.2. Proposal for Platelet Rich Plasma Market Players to deal with Covid-19 Pandemic Scenario

Chapter 6. Platelet Rich Plasma Market Dynamics Analysis and Trends

6.1. Market Dynamics
6.1.1. Market Drivers
6.1.1.1. Intensifying elderly population and mounting pervasiveness of orthopedic situtaions
6.1.1.2. Growing applications of platelet-rich plasma products in hair transplant and other cosmetic applications
6.1.2. Market Restraints
6.1.2.1. Restraint 1
6.1.3. Market Opportunities
6.1.3.1. Opportunity 1
6.1.3.2. Opportunity 2

Chapter 7. Global Platelet Rich Plasma Market: Competitive Landscape

7.1.1. Company Market Share/Positioning Analysis
7.1.1.1. Platelet Rich Plasma Market Revenue by Market Players (2015-2020)
7.1.1.2. Platelet Rich Plasma Market Revenue Market Share by Market Players (2015-2020)
7.1.2. Key Organic/Inorganic Strategies Adopted by Players
7.1.2.1. Product Portfolio Expansion, Geographic Expansion, Product Innovation
7.1.2.2. Merger and Acquisition, Collaboration and Partnerships
7.1.3. Market Players Landscape
7.1.3.1. List of Product Type Suppliers
7.1.3.2. List of End-users

Chapter 8. Global Platelet Rich Plasma Market, By Product Type

8.1. Platelet Rich Plasma Market, by Component, 2016-2030
8.1.1. Leukocyte Rich PRP
8.1.1.1. Market Revenue and Forecast (2016-2030)
8.1.2. Pure PRP
8.1.2.1. Market Revenue and Forecast (2016-2030)
8.1.3. Leukocyte Rich Fibrin
8.1.3.1. Market Revenue and Forecast (2016-2030)

Chapter 9. Global Platelet Rich Plasma Market, By Application

9.1. Platelet Rich Plasma Market, by Application, 2016-2030
9.1.1. Allogeneic PRP
9.1.1.1. Market Revenue and Forecast (2016-2030)
9.1.2. Autologous PRP
9.1.2.1. Market Revenue and Forecast (2016-2030)
9.1.3. Homologous PRP
9.1.3.1. Market Revenue and Forecast (2016-2030)

Chapter 10. Global Platelet Rich Plasma Market, By End-user

10.1. Platelet Rich Plasma Market, by End-user, 2016-2030
10.1.1. Cosmetic Surgery & Dermatology
10.1.1.1. Market Revenue and Forecast (2016-2030)
10.1.2. Orthopedic Surgery
10.1.2.1. Market Revenue and Forecast (2016-2030)
10.1.3. General Surgery
10.1.3.1. Market Revenue and Forecast (2016-2030)
10.1.4. Ophthalmic Surgery
10.1.4.1. Market Revenue and Forecast (2016-2030)
10.1.5. Neurosurgery
10.1.5.1. Market Revenue and Forecast (2016-2030)
10.1.6. Others
10.1.6.1. Market Revenue and Forecast (2016-2030)

Chapter 11. Global Platelet Rich Plasma Market, Regional Estimates and Trend Forecast

11.1. North America
11.1.1. Market Revenue Forecast by Product Type(2016-2030)
11.1.2. Market Revenue Forecast by Application (2016-2030)
11.1.3. Market Revenue Forecast by End-user (2016-2030)
11.1.4. U.S
11.1.4.1. Market Revenue Forecast (2016-2030)
11.1.5. Canada
11.1.5.1. Market Revenue Forecast (2016-2030)
11.2. Europe
11.2.1. Market Revenue Forecast by Product Type(2016-2030)
11.2.2. Market Revenue Forecast by Application (2016-2030)
11.2.3. Market Revenue Forecast by End-user (2016-2030)
11.2.4. UK
11.2.4.1. Market Revenue Forecast (2016-2030)
11.2.5. Germany
11.2.5.1. Market Revenue Forecast (2016-2030)
11.2.6. France
11.2.6.1. Market Revenue Forecast (2016-2030)
11.2.7. Rest of EU
11.2.7.1. Market Revenue Forecast (2016-2030)
11.3. Asia Pacific (APAC)
11.3.1. Market Revenue Forecast by Product Type(2016-2030)
11.3.2. Market Revenue Forecast by Application (2016-2030)
11.3.3. Market Revenue Forecast by End-user (2016-2030)
11.3.4. China
11.3.4.1. Market Revenue Forecast (2016-2030)
11.3.5. India
11.3.5.1. Market Revenue Forecast (2016-2030)
11.3.6. Japan
11.3.6.1. Market Revenue Forecast (2016-2030)
11.3.7. Rest of APAC
11.3.7.1. Market Revenue Forecast (2016-2030)
11.4. LATAM
11.4.1. Market Revenue Forecast by Product Type(2016-2030)
11.4.2. Market Revenue Forecast by Application (2016-2030)
11.4.3. Market Revenue Forecast by End-user (2016-2030)
11.4.4. Brazil
11.4.4.1. Market Revenue Forecast (2016-2030)
11.4.5. Rest of LATAM
11.4.5.1. Market Revenue Forecast (2016-2030)
11.5. Middle East and Africa (MEA)
11.5.1. Market Revenue Forecast by Product Type(2016-2030)
11.5.2. Market Revenue Forecast by Application (2016-2030)
11.5.3. Market Revenue Forecast by End-user (2016-2030)
11.5.4. GCC
11.5.4.1. Market Revenue Forecast (2016-2030)
11.5.5. North Africa
11.5.5.1. Market Revenue Forecast (2016-2030)
11.5.6. South Africa
11.5.6.1. Market Revenue Forecast (2016-2030)
11.5.7. Rest of MEA
11.5.7.1. Market Revenue Forecast (2016-2030)

Chapter 12. Company Profiles

12.1. Zimmer Biomet
12.1.1. Company Overview, Business Information, Regional Presence
12.1.2. Product Portfolio Analysis
12.1.2.1. Product Details, Specification, Application
12.1.3. Revenue, Price, and Gross Margin (2015-2020)
12.1.4. Recent Developments and Strategies
12.2. Arthrex, Inc.
12.2.1. Company Overview, Business Information, Regional Presence
12.2.2. Product Portfolio Analysis
12.2.2.1. Product Details, Specification, Application
12.2.3. Revenue, Price, and Gross Margin (2015-2020)
12.2.4. Recent Developments and Strategies
12.3. Harvest Technologies Corporation
12.3.1. Company Overview, Business Information, Regional Presence
12.3.2. Product Portfolio Analysis
12.3.2.1. Product Details, Specification, Application
12.3.3. Revenue, Price, and Gross Margin (2015-2020)
12.3.4. Recent Developments and Strategies
12.4. Stryker Corporation
12.4.1. Company Overview, Business Information, Regional Presence
12.4.2. Product Portfolio Analysis
12.4.2.1. Product Details, Specification, Application
12.4.3. Revenue, Price, and Gross Margin (2015-2020)
12.4.4. Recent Developments and Strategies
12.5. DePuy Synthes, Inc.
12.5.1. Company Overview, Business Information, Regional Presence
12.5.2. Product Portfolio Analysis
12.5.2.1. Product Details, Specification, Application
12.5.3. Revenue, Price, and Gross Margin (2015-2020)
12.5.4. Recent Developments and Strategies
12.6. Cesca Therapeutics, Inc.
12.6.1. Company Overview, Business Information, Regional Presence
12.6.2. Product Portfolio Analysis
12.6.2.1. Product Details, Specification, Application
12.6.3. Revenue, Price, and Gross Margin (2015-2020)
12.6.4. Recent Developments and Strategies
12.7. AdiStem Ltd.
12.7.1. Company Overview, Business Information, Regional Presence
12.7.2. Product Portfolio Analysis
12.7.2.1. Product Details, Specification, Application
12.7.3. Revenue, Price, and Gross Margin (2015-2020)
12.7.4. Recent Developments and Strategies
12.8. Exactech Inc.
12.8.1. Company Overview, Business Information, Regional Presence
12.8.2. Product Portfolio Analysis
12.8.2.1. Product Details, Specification, Application
12.8.3. Revenue, Price, and Gross Margin (2015-2020)
12.8.4. Recent Developments and Strategies
12.9. ISTO Biologics
12.9.1. Company Overview, Business Information, Regional Presence
12.9.2. Product Portfolio Analysis
12.9.2.1. Product Details, Specification, Application
12.9.3. Revenue, Price, and Gross Margin (2015-2020)
12.9.4. Recent Developments and Strategies
12.10. Nuo Therapeutics
12.10.1. Company Overview, Business Information, Regional Presence
12.10.2. Product Portfolio Analysis
12.10.2.1. Product Details, Specification, Application
12.10.3. Revenue, Price, and Gross Margin (2015-2020)
12.10.4. Recent Developments and Strategies

Chapter 13. Appendix

13.1. About Us
13.2. Glossary of Terms

Purchase This Premium Research Report @ https://www.precedenceresearch.com/checkout/1237

About Us

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings. We are obliged to serve our different client base present over the enterprises of medicinal services, healthcare, innovation, next-gen technologies, semiconductors, chemicals, automotive, and aerospace & defence, among different ventures, present globally.

Contact Us:

Mr. Alex

Sales Manager

Call: +1 9197 992 333

Email: sales@precedenceresearch.com

Web: https://www.precedenceresearch.com

Blog: https://precedenceresearchnews.wordpress.com

Follow us on LinkedIn | Twitter | Facebook

Precedence Research

Precedence Research is a worldwide market research and consulting organization. We give unmatched nature of offering to our customers present all around the globe across industry verticals. Precedence Research has expertise in giving deep-dive market insight along with market intelligence to our customers spread crosswise over various undertakings.

View all posts by Precedence Research →